Sirtex Medical Half Year Result – SRX focuses on balance sheet in preparation for takeover
SRX reported a 13.2% lift in half year profit, supported by higher margins offsetting a 0.4% fall in doses sold over the period. Margins expanded to over 30% of EBITDA as the companies restructure program starts to positively impact returns. 
Click Here to view report & video:

For more Reporting Season coverage: